Evidence for a gonadotropin from nonpregnant subjects that has physical, immunological, and biological similarities to human chorionic gonadotropin.
PDF (1.0M)
+4 authors
Journal: 1976/October - Proceedings of the National Academy of Sciences of the United States of America
ISSN: 0027-8424
PUBMED: 60763
Abstract:
Substances from urinary extracts of normal, nonpregnant subjects and human pituitary gonadotropin preparations were found to react similarly to human chorionic gonadotropin (hCG) in a radioimmunoassay system that is highly specific for hCG and without crossreactivity to human luteinizing hormone (hLH). The antiserum was produced in a rabbit immunized with a bovine albumin conjugate of the unique carboxyl-terminal peptide (residues 123-145) isolated from a tryptic digest of the reduced, S-carboxymethylated hCGbeta subunit. The antibody recognition site on the peptide was found to reside on the last 15 amino acid residues of the carboxyl-terminal peptide, as evidenced by the competitive binding activities against 125I-labeled hCG of a series of peptides chemically synthesized according to the carboxyl-terminal sequence of HCGbeta. In order to elucidate the nature of the crossreacting substance in urinary extracts, a human postmenopausal urinary preparation (Pergonal) and a kaolin-acetone extract of urine from a patient with Klinefelter's syndrome were subjected to gel chromatography on Sephadex G-100. The results indicate that fractions showing immunocrossreactivity with the antiserum to hCGbeta-carboxyl-terminal peptide coeluted with 125I-labeled hCG which was separated distinctly from hLH. The same fractions from this postmenopausal urinary gonadotropin preparation exhibited in vitro biological activity proportional to the immunocrossreactivity of the hCG-specific antiserum. Concentration of postmenopausal women's urine by acetone precipitation retained approximately five times more immunoreactivity per unit volume than kaolin-acetone extraction, when assayed with the antiserum to hCGbeta-carboxyl-terminal peptide.
Open in
PUBMED | PMC | Google Scholar | Wikipedia
Relations:
Content
Citations
(13)
References
(19)
Diseases
(1)
Drugs
(5)
Chemicals
(5)
Organisms
(1)
Processes
(2)
Anatomy
(1)
Similar articles
Articles by the same authors
Discussion board
Proc Natl Acad Sci U S A 73(8): 2885-2889
PMID: 60763

Evidence for a gonadotropin from nonpregnant subjects that has physical, immunological, and biological similarities to human chorionic gonadotropin.

Abstract

Substances from urinary extracts of normal, nonpregnant subjects and human pituitary gonadotropin preparations were found to react similarly to human chorionic gonadotropin (hCG) in a radioimmunoassay system that is highly specific for hCG and without crossreactivity to human luteinizing hormone (hLH). The antiserum was produced in a rabbit immunized with a bovine albumin conjugate of the unique carboxyl-terminal peptide (residues 123-145) isolated from a tryptic digest of the reduced, S-carboxymethylated hCGbeta subunit. The antibody recognition site on the peptide was found to reside on the last 15 amino acid residues of the carboxyl-terminal peptide, as evidenced by the competitive binding activities against 125I-labeled hCG of a series of peptides chemically synthesized according to the carboxyl-terminal sequence of HCGbeta. In order to elucidate the nature of the crossreacting substance in urinary extracts, a human postmenopausal urinary preparation (Pergonal) and a kaolin-acetone extract of urine from a patient with Klinefelter's syndrome were subjected to gel chromatography on Sephadex G-100. The results indicate that fractions showing immunocrossreactivity with the antiserum to hCGbeta-carboxyl-terminal peptide coeluted with 125I-labeled hCG which was separated distinctly from hLH. The same fractions from this postmenopausal urinary gonadotropin preparation exhibited in vitro biological activity proportional to the immunocrossreactivity of the hCG-specific antiserum. Concentration of postmenopausal women's urine by acetone precipitation retained approximately five times more immunoreactivity per unit volume than kaolin-acetone extraction, when assayed with the antiserum to hCGbeta-carboxyl-terminal peptide.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.0M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.
icon of scanned page 2885
2885
icon of scanned page 2886
2886
icon of scanned page 2887
2887
icon of scanned page 2888
2888
icon of scanned page 2889
2889

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Goldstein DP, Kosasa TS, Skarim AT. The clinical application of a specific radioimmunoassay for human chorionic gondotropin in trophoblastic and nontrophoblastic tumors. Surg Gynecol Obstet. 1974 May;138(5):747–751. [PubMed] [Google Scholar]
  • Vaitukaitis JL, Braunstein GD, Ross GT. A radioimmunoassay which specifically measures human chorionic gonadotropin in the presence of human luteinizing hormone. Am J Obstet Gynecol. 1972 Jul 15;113(6):751–758. [PubMed] [Google Scholar]
  • Braunstein GD, Vaitukaitis JL, Carbone PP, Ross GT. Ectopic production of human chorionic gonadotrophin by neoplasms. Ann Intern Med. 1973 Jan;78(1):39–45. [PubMed] [Google Scholar]
  • Louvet JP, Ross GT, Birken S, Canfield RE. Absence of neutralizing effect of antisera to the unique structural region of human chorionic gonadotropin. J Clin Endocrinol Metab. 1974 Dec;39(6):1155–1158. [PubMed] [Google Scholar]
  • Morgan FJ, Birken S, Canfield RE. Letter: Human chorionic gonadotropin: a proposal for the amino acid sequence. Mol Cell Biochem. 1973 Nov 15;2(1):97–99. [PubMed] [Google Scholar]
  • Morgan FJ, Birken S, Canfield RE. The amino acid sequence of human chorionic gonadotropin. The alpha subunit and beta subunit. J Biol Chem. 1975 Jul 10;250(13):5247–5258. [PubMed] [Google Scholar]
  • ALBERT A. Human urinary gonadotropin. Recent Prog Horm Res. 1956;12:227–301. [PubMed] [Google Scholar]
  • DONINI P, PUZZUOLI D, MONTEZEMOLO R. PURIFICATION OF GONADOTROPHIN FROM HUMAN MENOPAUSAL URINE. Acta Endocrinol (Copenh) 1964 Mar;45:321–328. [PubMed] [Google Scholar]
  • Morgan FJ, Canfield RE. Nature of the subunits of human chorionic gonadotropin. Endocrinology. 1971 Apr;88(4):1045–1053. [PubMed] [Google Scholar]
  • Morgan FJ, Canfield RE, Vaitukaitis JL, Ross GT. Properties of the subunits of human chorionic gonadotropin. Endocrinology. 1974 Jun;94(6):1601–1606. [PubMed] [Google Scholar]
  • MERRIFIELD RB. SOLID-PHASE PEPTIDE SYNTHESIS. 3. AN IMPROVED SYNTHESIS OF BRADYKININ. Biochemistry. 1964 Sep;3:1385–1390. [PubMed] [Google Scholar]
  • Vaitukaitis J, Robbins JB, Nieschlag E, Ross GT. A method for producing specific antisera with small doses of immunogen. J Clin Endocrinol Metab. 1971 Dec;33(6):988–991. [PubMed] [Google Scholar]
  • Odell WD, Ross GT, Rayford PL. Radioimmunoassay for luteinizing hormone in human plasma or serum: physiological studies. J Clin Invest. 1967 Feb;46(2):248–255.[PMC free article] [PubMed] [Google Scholar]
  • Rodbard D, Lewald JE. Computer analysis of radioligand assay and radioimmunoassay data. Acta Endocrinol Suppl (Copenh) 1970;147:79–103. [PubMed] [Google Scholar]
  • Hodgen GD, Wilks JW, Vaitukaitis JL, Chen HC, Papkoff H, Ross GT. A new radioimmunoassay for follicle-stimulating hormone in macaques: ovulatory menstrual cycles. Endocrinology. 1976 Jul;99(1):137–145. [PubMed] [Google Scholar]
  • Dufau ML, Mendelson CR, Catt KJ. A highly sensitive in vitro bioassay for luteinizing hormone and chorionic gonadotropin: testosterone production by dispersed Leydig cells. J Clin Endocrinol Metab. 1974 Sep;39(3):610–613. [PubMed] [Google Scholar]
  • ALBERT A, DERNER I. Contamination of gonadotropin standards. J Clin Endocrinol Metab. 1960 Oct;20:1411–1416. [PubMed] [Google Scholar]
  • Braunstein GD, Rasor J, Wade ME. Presence in normal human testes of a chorionic-gonadotropin-like substance distinct from human luteinizing hormone. N Engl J Med. 1975 Dec 25;293(26):1339–1343. [PubMed] [Google Scholar]
  • Vaitukaitis JL. Human chorionic gonadotropin as a tumor marker. Ann Clin Lab Sci. 1974 Jul-Aug;4(4):276–280. [PubMed] [Google Scholar]
Copyright notice
Abstract
Substances from urinary extracts of normal, nonpregnant subjects and human pituitary gonadotropin preparations were found to react similarly to human chorionic gonadotropin (hCG) in a radioimmunoassay system that is highly specific for hCG and without crossreactivity to human luteinizing hormone (hLH). The antiserum was produced in a rabbit immunized with a bovine albumin conjugate of the unique carboxyl-terminal peptide (residues 123-145) isolated from a tryptic digest of the reduced, S-carboxymethylated hCGbeta subunit. The antibody recognition site on the peptide was found to reside on the last 15 amino acid residues of the carboxyl-terminal peptide, as evidenced by the competitive binding activities against 125I-labeled hCG of a series of peptides chemically synthesized according to the carboxyl-terminal sequence of HCGbeta. In order to elucidate the nature of the crossreacting substance in urinary extracts, a human postmenopausal urinary preparation (Pergonal) and a kaolin-acetone extract of urine from a patient with Klinefelter's syndrome were subjected to gel chromatography on Sephadex G-100. The results indicate that fractions showing immunocrossreactivity with the antiserum to hCGbeta-carboxyl-terminal peptide coeluted with 125I-labeled hCG which was separated distinctly from hLH. The same fractions from this postmenopausal urinary gonadotropin preparation exhibited in vitro biological activity proportional to the immunocrossreactivity of the hCG-specific antiserum. Concentration of postmenopausal women's urine by acetone precipitation retained approximately five times more immunoreactivity per unit volume than kaolin-acetone extraction, when assayed with the antiserum to hCGbeta-carboxyl-terminal peptide.
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.